Summary

An analysis of 12 clinical trials investigated the correlation between coenzyme Q10 supplementation, a cofactor of cellular energy metabolism, and hypertension. Based on all results, the researchers concluded that coenzyme Q10 supplementation can reduce systolic blood pressure by up to 17 points (mmHg) and diastolic blood pressure by up to 10 points. Among the clinical trials evaluated, 3 randomized controlled trials involving a total of 120 participants showed a highly significant reduction in blood pressure. Further details can be found in the study.

References

Chuen Wen Tan, Liam Pock Ho , Shirin Kalimuddin , Benjamin Pei Zhi Cherng , Yii Ean Teh , Siew Yee Thien , Hei Man Wong , Paul Jie Wen Tern , Manju Chandran , Jason Wai Mun Chay , Chandramouli Nagarajan, Rehena Sultana , Jenny Guek Hong Low , Heng Joo Ng

 

Link to article >>